Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: August 10, 2022

Details for Patent: 6,375,978

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Summary for Patent: 6,375,978
Title: Rate controlling membranes for controlled drug delivery devices
Abstract:This invention provides rate controlling membranes for controlled drug delivery devices that are stable over time and exhibit more predictable and consistent membrane functionality. According to another aspect, the membranes have enhanced permeability. According to the invention, the rate controlling membrane of a controlled drug delivery device is subjected to a pre-treatment annealing process wherein it is subjected to an elevated temperature for a predetermined time period and subsequently cooled to ambient conditions before incorporation into a controlled drug delivery device.
Inventor(s): Kleiner; Lothar W. (Los Altos, CA), Gale; Robert M. (Los Altos, CA), Berggren; Randall G. (Livermore, CA), Tong; Gilbert T. (Union City, CA), Chen; Guohua (Sunnyvale, CA), Dionne; Keith E. (Cambridge, MA), Houston; Paul R. (Hayward, CA)
Assignee: ALZA Corporation (Mountain View, CA)
Application Number:09/213,213
Patent Claim Types:
see list of patent claims
Delivery; Device; Use;

Drugs Protected by US Patent 6,375,978

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,375,978

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 014065 See Plans and Pricing
Austria 223208 See Plans and Pricing
Australia 1623099 See Plans and Pricing
Canada 2315890 See Plans and Pricing
China 100388916 See Plans and Pricing
China 1282240 See Plans and Pricing
Germany 69807748 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.